Clinical Trial Update: Clinical Study of Subretinal Transplantation of Human Embryo Stem Cell Derived Retinal Pigment Epitheliums in Treatment of Macular Degeneration Diseases [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical study evaluating subretinal transplantation of human embryonic stem cell-derived retinal pigment epithelium for macular degeneration and Star…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Stargardt Macular Dystrophy

Drugs mentioned

• human embryonic stem cell-derived retinal pigment epithelium

Snippet

Sponsor: Southwest Hospital, China | Conditions: Macular Degeneration, Stargardt's Macular Dystrophy | Phase 1, Phase 2 | Status: UNKNOWN